CDMO News
Pluri Partners with Bar-Ilan to Develop MAIT Cell Therapy for Solid Tumors
Pluri Inc., has announced a new collaboration with Bar-Ilan University’s research and development arm, BIRAD. Funded by the Israel Innovation Authority (IIA), the project will support the development of Placental Mucosal Associated Invariant T (MAIT) cells as a novel treatment
29 October 2024